CLINICAL_TRIALS
trial_result
· 2021-11-23
Clinical Trial Update: Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC [Phase 4]
Summary
Phase 4 trial investigating cipterbin combined with vinorelbine for metastatic breast cancer is ongoing with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhejiang Cancer Hospital | Conditions: Metastatic Breast Cancer | Phase 4 | Status: UNKNOWN